Amyloid Cascade and Tau Pathology Cerebrospinal Fluid Markers in Mild Cognitive Impairment with regards to Alzheimer's Disease Cerebral Metabolic Signature-Reference-Cited by-同舟云学术

Amyloid Cascade and Tau Pathology Cerebrospinal Fluid Markers in Mild Cognitive Impairment with regards to Alzheimer's Disease Cerebral Metabolic Signature

Published:2013-06-18 Issue:2 Volume:36 Page:401-408
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Alexopoulos Panagiotis¹,Guo Liang-Hao¹,Jiang Meizi²,Bujo Hideaki²,Grimmer Timo¹,Förster Stefan³⁴,Drzezga Alexander³⁵,Kurz Alexander¹,Perneczky Robert¹⁶

Affiliation:

1. Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany

2. Department of Genome Research and Clinical Application, Chiba University, Graduate School of Medicine, Chiba, Japan

3. Department of Nuclear Medicine, Technische Universität München, Munich, Germany

4. TUM Neuroimaging Center (TUM-NIC), Technische Universität München, Munich, Germany

5. Klinik und Poliklinik für Nuklearmedizin, Uniklinik Köln, Cologne, Germany

6. Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial association between distributed β-amyloid and tau varies with cognition;2023-09-29

2. Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment;Aging Clinical and Experimental Research;2021-07-20

3. Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer’s Disease with Dementia;Journal of Alzheimer's Disease;2019-05-07

4. Potential value of soluble APP α and APP β in CSF as biomarkers of dementia disorders: Unresolved issues and perspectives;Neurology and Clinical Neuroscience;2018-06-21

5. Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer’s Disease;Dementia and Geriatric Cognitive Disorders;2018